The COVID-19 Pandemic – News and Features

A new app has been launched that tracks symptoms related to novel coronavirus (COVID-19), allowing anyone to self-report daily.

Whilst the classic symptoms of COVID-19 – fever, persistent dry cough, shortness of breath – are now drummed into anyone following the spread of this novel coronavirus, a potential new symptom has begun to be reported by medical experts – a loss of smell or taste.

Researchers from the University of Oxford have launched a new clinical trial to test the effects of potential drug treatments for patients with COVID-19.

Scientists discovered that coronavirus is detectable for up to three hours in aerosols, up to four hours on copper, up to 24 hours on cardboard and up to two to three days on plastic and stainless steel.

An article published in the Journal of Ultrasound in Medicine features some of the first lung ultrasound images in patients with the Coronavirus, and explores the roles the technique could have during the pandemic.

Technology Networks spoke with Yossi Pollak, CEO, Sight Diagnostics, to learn more about OLO and how it is being used to minimize the challenges of handling and analyzing blood samples from COVID-19 infected patients.

Six coronavirus research projects, including two focused on vaccine development, will be the first to benefit from a share of £20 million in UK government investment.

In this article, Technology Networks explore the current global efforts underway to develop a vaccine against COVID-19.

The U.S. Food and Drug Administration (FDA) has issued guidance for industry, investigators and institutional review boards conducting clinical trials during the novel coronavirus (COVID-19) pandemic.

CloudLIMS is making its "in the cloud" LIMS free of charge to any research facility or diagnostics laboratory doing SARS-CoV-2 or COVID-19 research or testing, be it any part of the world.